Frontiers in endocrinology · 2025
The effect of Tai Chi on glycemic control in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sun Yawei, Li Quanzhi, Xue Weiqi
Аннотация
OBJECTIVE: This study aimed to investigate the effects of Tai Chi on fasting blood glucose (FBG), HbA1c, blood lipids, blood pressure, and inflammatory markers in patients with type 2 diabetes mellitus (T2DM) through a meta-analysis.
METHODS: We systematically searched PubMed, Cochrane Library, CNKI, CBM, WanFang, Web of Science, and Embase databases for randomized controlled trials (RCTs) evaluating Tai Chi interventions in T2DM patients. Statistical analyses were performed using Review Manager 5.4 software with random-effects models.
RESULTS: Compared to the control group, Tai Chi significantly reduced: FBG(SMD= -0.57, 95% CI [-0.92,-0.23], P =0.001), HbA1c(MD=-0.73, 95%CI[-0.98, -0.49], P<0.00001), TG(SMD=-0.50, 95%CI[-0.91, -0.09], P =0.02), LDL-C(SMD=-0.70, 95%CI[-1.26, -0.15], P =0.01), hs-CRP(SMD=-0.71, 95%CI[-1.10, -0.31], P =0.0005), IL-6(SMD=-2.11, 95%CI[-2.88, -1.34], P<0.00001), TNF-α(SMD=-3.25, 95%CI[-3.25, -0.53], P =0.006). Subgroup analyses indicated optimal FBG reduction with: The standardized 24-form Tai Chi routine; Interventions ≥12 weeks in duration; Exercise frequency >5 sessions/week; Daily exercise duration ≥60 minutes.
CONCLUSION: Tai Chi demonstrates clinically meaningful benefits for T2DM management. Future RCTs should explore age-specific (e.g., pediatric vs. geriatric) and sex-stratified responses to inform personalized exercise prescriptions.
METHODS: We systematically searched PubMed, Cochrane Library, CNKI, CBM, WanFang, Web of Science, and Embase databases for randomized controlled trials (RCTs) evaluating Tai Chi interventions in T2DM patients. Statistical analyses were performed using Review Manager 5.4 software with random-effects models.
RESULTS: Compared to the control group, Tai Chi significantly reduced: FBG(SMD= -0.57, 95% CI [-0.92,-0.23], P =0.001), HbA1c(MD=-0.73, 95%CI[-0.98, -0.49], P<0.00001), TG(SMD=-0.50, 95%CI[-0.91, -0.09], P =0.02), LDL-C(SMD=-0.70, 95%CI[-1.26, -0.15], P =0.01), hs-CRP(SMD=-0.71, 95%CI[-1.10, -0.31], P =0.0005), IL-6(SMD=-2.11, 95%CI[-2.88, -1.34], P<0.00001), TNF-α(SMD=-3.25, 95%CI[-3.25, -0.53], P =0.006). Subgroup analyses indicated optimal FBG reduction with: The standardized 24-form Tai Chi routine; Interventions ≥12 weeks in duration; Exercise frequency >5 sessions/week; Daily exercise duration ≥60 minutes.
CONCLUSION: Tai Chi demonstrates clinically meaningful benefits for T2DM management. Future RCTs should explore age-specific (e.g., pediatric vs. geriatric) and sex-stratified responses to inform personalized exercise prescriptions.